{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:26:48Z","timestamp":1772890008286,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":865,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.repc.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:17:01Z","timestamp":1479341821000},"page":"645-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mortality benefit of long-term angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after successful percutaneous coronary intervention in non-ST elevation acute myocardial infarction"],"prefix":"10.1016","volume":"35","author":[{"given":"Mar\u00eda Cristina","family":"Gonz\u00e1lez-Cambeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Abu-Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Raposeiras-Roub\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Pe\u00f1a-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Garc\u00eda-Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2016.07.003_bib0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM198807143190204","article-title":"Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction","volume":"319","author":"Pfeffer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0200","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJM199209033271002","article-title":"Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)","volume":"327","author":"Swedberg","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0205","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0140-6736(91)90202-Z","article-title":"Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition","volume":"337","author":"Sharpe","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2016.07.003_bib0210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0215","first-page":"821","article-title":"Effect of ramipril on mortality, morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2016.07.003_bib0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.CIR.89.1.68","article-title":"Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril","volume":"89","author":"St John Sutton","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2016.07.003_bib0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0735-1097(94)90543-6","article-title":"Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction","volume":"24","author":"Wright","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2016.07.003_bib0230","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9149(99)80223-9","article-title":"Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction","volume":"76","author":"Schulman","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.07.003_bib0235","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0240","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0245","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(95)90866-8","article-title":"Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2016.07.003_bib0250","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2016.07.003_bib0255","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0735-1097(96)00113-1","article-title":"Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS)","volume":"28","author":"van Gilst","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2016.07.003_bib0260","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(97)04442-5","article-title":"Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy","volume":"349","author":"Hall","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2016.07.003_bib0265","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2016.07.003_bib0270","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0275","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: a meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2016.07.003_bib0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.repc.2016.07.003_bib0285","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"\u03b2-Blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.repc.2016.07.003_bib0290","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1001\/jama.287.23.3087","article-title":"Early statin initiation and outcomes in patients with acute coronary syndromes","volume":"287","author":"Newby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2016.07.003_bib0295","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","article-title":"ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2016.07.003_bib0300","first-page":"e663","article-title":"2012 ACCF\/AHA focused update incorporated into the ACCF\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction","volume":"127","author":"Anderson","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2016.07.003_bib0305","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jcin.2012.06.023","volume":"5","author":"Raposeiras-Roub\u00edn","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repc.2016.07.003_bib0310","first-page":"222","article-title":"Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome","volume":"1","author":"Abu-Assi","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.repc.2016.07.003_bib0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.2013.285063","article-title":"How to use a subgroup analysis: users\u2019 guide to the medical literature","volume":"311","author":"Sun","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2016.07.003_bib0320","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.repc.2016.07.003_bib0325","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.repc.2016.07.003_bib0330","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwj047","article-title":"Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect","volume":"163","author":"Kurth","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.repc.2016.07.003_bib0335","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2016.07.003_bib0340","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0345","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"\u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2016.07.003_bib0350","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0355","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/heartjnl-2013-304348","article-title":"Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study","volume":"99","author":"Gunnell","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.repc.2016.07.003_bib0360","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archinte.167.1.68","article-title":"External validity of clinical trials in acute myocardial infarction","volume":"167","author":"Steg","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.repc.2016.07.003_bib0365","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2369-15-53","article-title":"Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis","volume":"15","author":"Shah","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.repc.2016.07.003_bib0370","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.amjcard.2009.12.032","article-title":"Effect of angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction","volume":"105","author":"Milonas","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.07.003_bib0375","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjcard.2014.04.046","article-title":"Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA\/KORA Myocardial Infarction Registry)","volume":"114","author":"Amann","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2016.07.003_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2014.03.055","article-title":"Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker","volume":"114","author":"Hara","year":"2014","journal-title":"Am J Cardiol"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255116302256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255116302256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:04:39Z","timestamp":1760108679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255116302256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0870255116302256"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2016.07.003","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality benefit of long-term angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after successful percutaneous coronary intervention in non-ST elevation acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}